Summary
Circulating interferon was found in volunteers immunized with 3.0 ml and 1.0 ml doses of human diploid cell strain (HDCS) rabies vaccines. Peak interferon titres were observed 17–25 hours after primary vaccination and the response diminished upon revaccination. The response was dose-related and did not correlate with the antigenic value of the vaccines or with the titre of infectious virus in the vaccines before inactivation.
Similar content being viewed by others
References
Baer, G. M., Cleary, W. F.: A model in mice for the pathogenesis and treatment of rabies. J. inf. Dis.125, 520–527 (1972).
Baer, G. M., Shaddock, J. H., Moore, S. A., Yager, P. A., Baron, S. S., Levy, H. B.: Successful prophylaxis against rabies in mice and rhesus monkeys: the interferon system and vaccine. J. inf. Dis.136, 286–291 (1977).
Baer, G. M., Yager, P. A.: A mouse model for post-exposure rabies prophylaxis. The comparative efficacy of two vaccines and of antiserum administration. J. gen. Virol.36, 51–58 (1977).
Christofinis, G. J.: Biological characteristics of cell line GL-V3 derived from the kidney of a vervet monkey(Ceriopithecus aethiops). J. med. Microbiol.3, 251–258 (1970).
Crick, J.: The vaccination of man and other animals against rabies. Postgrad. med. J.49, 551–564 (1973).
Fenje, P., Postic, B.: Protection of rabbits against experimental rabies by poly I—poly C. Nature226, 171–172 (1970).
Fenje, P., Postic, B.: Prophylaxis of experimental rabies with the polyriboinosinic-polyribocytidylic acid complex. J. inf. Dis.123, 426–428 (1971).
Fitzgerald, E. A., Green, O. L., Seligman, E. B.: Rabies vaccine potency testing: a comparison between the antibody-binding test and the NIH test. Symposia Series in Immunobiological Standardization No. 21, 300–307. Basel: Karger 1974.
Habel, K.: Post-exposure vaccination and antiserum prophylaxis of rabies in man. In: Proceedings of the National Rabies Symposium p. 89. National Communicable Diseases Center, Atlanta, Ga., 1966.
Harmon, M. W., Janis, B.: Therapy of murine rabies after exposure: efficacy of polyriboinosic-polyribocytidylic acid alone and in combination with three rabies vaccines. J. inf. Dis.132, 241–249 (1975).
Hilfenhaus, J., Karges, H. E., Weinmann, E., Barth, R.: Effect of administered human interferon on experimental rabies in monkeys. Infect. Immun.11, 1156 to 1158 (1975).
Janis, B., Habel, K.: Rabies in rabbits and mice: protective effect of polyriboinosic-polyribocytidylic acid. J. inf. Dis.125, 345–352 (1972).
Kaplan, M. M., Cohen, D., Koprowski, H., Dean, D., Ferrigan, L.: Studies on the local treatment of wounds for the prevention of rabies. Bull. Wld. Hlth. Org.26, 765–775 (1962).
Koprowski, H., Black, J.: Studies on chick embryo-adapted rabies virus. V. Protection of animals with antiserum and living attenuated virus after expsoure to street strain of rabies virus. J. Immunol.72, 85–93 (1954).
Kuwert, E. K., Marcus, I., Hoher, P. G.: Neutralizing and complement fixing antibody response in pre- and post-exposure vaccinees to a rabies vaccine produced in human diploid cells. J. biol. Stand.4, 249–262 (1976).
Kuwert, E. K., Marcus, I., Werner, J., Scheiermann, N., Hoher, P. G., Thraenhart, O., Hierholzer, E., Wiktor, T. J., Koprowski, H.: Post-exposure use of human diploid cell culture rabies vaccine. In: Joint WHO/IABS Symposium on the standardization of cell substrates for the production of virus vaccines.Perkins, F. T., Regamey, R. H. (eds.), Developments in Biological Standardization 37, 273–286. Basel: S. Karger 1977.
Nicholson, K. G., Turner, G. S.: Studies with HDCS rabies vaccine and human antirabies immunoglobulin in man. In: Joint WHO/IABS Symposium on the standardization of rabies vaccines for human use produced in tissue culture. (Rabies III).Hennessen, W., Regamey, R. H. (eds.), Developments in Biological Standardization 40, 115–120. Basel: S. Karger 1978.
Postic, B., Fenje, P.: Effect of administered interferon on rabies in rabbits. Appl. Microbiol.22, 428–431 (1971).
Sikes, R. K., Cleary, W. F., Koprowski, M., Wiktor, T. J., Kaplan, M. M.: Effective protection of monkeys against death from street virus by post-exposure administration of tissue-culture rabies vaccine. Bull. Wld. Hlth. Org.45, 1–11 (1971).
Sikes, R. K., Peacock, G. V., Acha, P., Arko, R. J., Dierks, R.: Rabies vaccines: duration of immunity study in dogs. Amer. vet. med. Ass.159, 1491–1499 (1971).
Turner, G. S.: Rabies vaccines and interferon. J. Hyg. (Camb.)70, 445–453 (1972).
Vieuchange, J.: Interference entre le virus vaccinal et le virus rabique, rôle éventuel d'un interferon. Arch. ges. Virusforsch.22, 87–96 (1967).
Vieuchange, J., Fayaz, A.: Essais de prévention de la rage expérimentale du lapin par un extrait tissulaire de type ‘interferon’ injecté pendant la periode d'incubation. Compt. Rend. Acad. Sci.268, 991–993 (1969).
Wiktor, T. J., Postic, B., Ho, M., Koprowski, H.: Role of interferon induction in the protective activity of rabies vaccines. J. inf. Dis.126, 408–418 (1972).
Yen, C. H.: Protective value of antiviral serum in experimental rabies infection. Proc. Soc. exp. Biol. Med.49, 533–537 (1942).
Author information
Authors and Affiliations
Additional information
With 1 Figure
Rights and permissions
About this article
Cite this article
Nicholson, K.G., Kuwert, E.K., Werner, J. et al. Interferon response to human diploid cell strain rabies vaccines in man. Archives of Virology 61, 35–39 (1979). https://doi.org/10.1007/BF01320589
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01320589